Clinical Trials · NCT00288080
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Radiation Therapy Oncology Group
- Enrollment
- 612
- Start date
- Dec 2005
- Locations
- 254 sites, United States, Canada
- Primary endpoint
- Overall Survival